394 related articles for article (PubMed ID: 18256440)
1. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
Turell MJ; Parker MD
Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
[TBL] [Abstract][Full Text] [Related]
2. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
[TBL] [Abstract][Full Text] [Related]
3. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
[TBL] [Abstract][Full Text] [Related]
5. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
Rosas CT; Paessler S; Ni H; Osterrieder N
Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
[TBL] [Abstract][Full Text] [Related]
6. Infection and dissemination of Venezuelan equine encephalitis virus in the epidemic mosquito vector, Aedes taeniorhynchus.
Smith DR; Arrigo NC; Leal G; Muehlberger LE; Weaver SC
Am J Trop Med Hyg; 2007 Jul; 77(1):176-87. PubMed ID: 17620651
[TBL] [Abstract][Full Text] [Related]
7. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
Phillpotts RJ; Lescott TL; Jacobs SC
Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
[TBL] [Abstract][Full Text] [Related]
8. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
[TBL] [Abstract][Full Text] [Related]
9. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
Elvin SJ; Bennett AM; Phillpotts RJ
J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
[TBL] [Abstract][Full Text] [Related]
11. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.
Turell MJ; Ludwig GV; Kondig J; Smith JF
Am J Trop Med Hyg; 1999 Jun; 60(6):1041-4. PubMed ID: 10403340
[TBL] [Abstract][Full Text] [Related]
12. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
Turell MJ; O'Guinn ML; Parker MD
Am J Trop Med Hyg; 2003 Feb; 68(2):218-21. PubMed ID: 12641414
[TBL] [Abstract][Full Text] [Related]
13. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
[TBL] [Abstract][Full Text] [Related]
14. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
[TBL] [Abstract][Full Text] [Related]
15. IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.
Rossi SL; Guerbois M; Gorchakov R; Plante KS; Forrester NL; Weaver SC
Virology; 2013 Mar; 437(2):81-8. PubMed ID: 23351391
[TBL] [Abstract][Full Text] [Related]
16. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.
Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS
Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186
[TBL] [Abstract][Full Text] [Related]
17. Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III.
Phillpotts RJ
Virus Res; 2006 Sep; 120(1-2):107-12. PubMed ID: 16621103
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates.
Dupuy LC; Richards MJ; Reed DS; Schmaljohn CS
Vaccine; 2010 Oct; 28(46):7345-50. PubMed ID: 20851089
[TBL] [Abstract][Full Text] [Related]
20. A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).
Fine DL; Jenkins E; Martin SS; Glass P; Parker MD; Grimm B
J Virol Methods; 2010 Feb; 163(2):424-32. PubMed ID: 19903494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
